In 2023, China's share of scientific publications among the world's 10% top-cited publications in drug discovery stood notably strong. The forecast from 2024 to 2028 shows a steady increase from 13.3% to 14.47%, reflecting a consistent positive growth trajectory. Year-on-year, there is a slight but progressive growth, indicating China's expanding influence in global drug discovery research. Over the five-year period, this corresponds to a compounded annual growth rate, demonstrating sustained advancement in academic impact.
Future trends to watch for include China's potential to enhance its global standing by further improving research quality and international collaborations, aiming to become a dominant force in innovative drug discovery research.
